Depression gene

Details Depression gene Depression gene

2006-05-26

2008-08-12

Carlson, Karen Cochrane (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07410944

ABSTRACT:
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.

REFERENCES:
patent: 6291643 (2001-09-01), Zou et al.
patent: 6346607 (2002-02-01), Wang
patent: 7052853 (2006-05-01), Shattuck et al.
patent: WO 02/057790 (2002-07-01), None
La Pia et al. 1992; Evaluation of the efficacy, tolerability, and therapeutic profile of fluoxetine versus mianserin in the treatment of depressive disorders in the elderly. Current Therapeutic Research 52(6): 847-858.
Chiou et al. 2006; Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cells. Biochem Biophys. Res. Commun. 343: 391-400.
Dunner 1998; Treatment of dysthymic disorder. Depression and Anxiety 8(Suppl. 1): 54-58.
Acehan et al., “Three-Dimensional Structure of the Apoptosome: Implications for Assembly, Procaspase-9 Binding, and Activation”,Molecular Cell, Feb. 2002, 9:423-432.
Belmokhtar et al., “Apoptosome-independent Pathway for Apoptosis”,The Journal of Biological Chemistry, Aug. 8, 2003, 278(32):29571-29580.
Day et al., “Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1”,Cell Death and Differentiation, 1999, 6:1125-1132.
Hu et al., “Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis”,The EMBO Journal, 1999, 18(13):3586-3595.
Li et al., “Cytochrome c Deficiency Causes Embryonic Lethality and Attenuates Stress-Induced Apoptosis”,Cell, May 12, 2000, 101:389-399.
Li et al., “Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade”,Cell, Nov. 14, 1997, 91:479-489.
Nestler et al., “Neurobiology of Depression”,Neuron, Mar. 28, 2002, 34:13-25.
Nguyen, “Direct activation of the apoptosis machinery as a mechanism to target cancer cells”,PNAS, Jun. 24, 2003, 100(13):7533-7538.
Qin et al., “Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1”,Nature, Jun. 10, 1999, 399:549-557.
Santarelli et al., “Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants”,Science, Aug. 8, 2003, 301:805-809.
Shiozaki et al., “Oligomerization and activation of caspase-9, induced by Apaf-1 CARD”,PNAS, Apr. 2, 2002, 99(7):4197-4202.
Vaux et al., “CED-4—The Third Horseman of Apoptosis”,Cell, Aug. 8, 1997, 90:389-390.
Walke et al., “A comparison of the expression and properties of Apaf-1 and Apaf-1L”,Brain Research Interactive, Sep. 12, 2000, 886:73-81.
Yakovlev et al., “Differential Expression of Apoptotic Protease-Activating Factor-1 and Caspase-3 Genes and Susceptibility to Apoptosis during Brain Development and after Traumatic Brain Injury”,The Journal of Neuroscience, Oct. 1, 2001, 21(19):7439-7446.
Yoshida et al., “Apaf1 is Required for Mitochondrial Pathways of Apoptosis and Brian Development”,Cell, Sep. 18, 1998, 94:739-750.
Zou et al., “An APAF-1-Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9”,The Journal of Biological Chemistry, Apr. 23, 1999, 274(17):11549-11556.
Zou et al., “Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c-Dependent Activation of Caspase-3”,Cell, Aug. 8, 1997, 90:405-413.

Affiliated with

Also associated with

Rating

Depression gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Depression gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depression gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4003590